Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
or

Synergy Pharma (SGYP)

Synergy Pharma (SGYP)
0.03 -0.03 (-52.00%) 03/07/19 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Quote Overview for Thu, Mar 7th, 2019
Day Low
0.03
Day High
0.06
Open 0.06
Previous Close 0.06 0.06
Volume 51,182,801 51,182,801
Avg Vol 22,819,135 22,819,135
Stochastic %K 2.46% 2.46%
Weighted Alpha -78.96 -78.96
5-Day Change -0.05 (-62.50%) -0.05 (-62.50%)
52-Week Range 0.03 - 2.23 0.03 - 2.23
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,441
  • Shares Outstanding, K 248,037
  • Annual Sales, $ 16,820 K
  • Annual Income, $ -224,340 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 4.94
  • Price/Sales 0.18
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.59
  • Most Recent Earnings $-0.15 on 05/10/18
  • Next Earnings Date 03/07/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.18
  • Growth Rate Est. (year over year) +555,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.03 unch
on 03/07/19
Period Open: 0.32
0.32 -90.77%
on 02/20/19
-0.29 (-90.63%)
since 02/07/19
3-Month
0.03 unch
on 03/07/19
Period Open: 0.36
0.47 -93.68%
on 01/24/19
-0.33 (-91.67%)
since 12/07/18
52-Week
0.03 unch
on 03/07/19
Period Open: 2.23
2.23 -98.65%
on 03/08/18
-2.20 (-98.65%)
since 03/07/18

Business Summary

Synergy Pharmaceuticals, Inc. is a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. Its lead drug candidate plecanatide is a guanylyl cyclase C receptor agonist, to treat GI disorders, primarily chronic constipation and constipation-predominant-...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 0.08
1st Resistance Point 0.05
Last Price 0.03
1st Support Level 0.02
2nd Support Level 0.01
3rd Support Level N/A

See More

52-Week High 2.23
Fibonacci 61.8% 1.39
Fibonacci 50% 1.13
Fibonacci 38.2% 0.87
Last Price 0.03
52-Week Low 0.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades